Cian Healthcare Seeks Shareholder Nod for ₹100 Crore Funding and RPTs

Cian Healthcare Limited is seeking member approval through a postal ballot for crucial financial and strategic resolutions, including enhancing borrowing limits to ₹100 crore and authorizing material related party transactions (RPTs).

What just happened

The company is conducting a postal ballot, with remote e-voting from June 10 to July 9, 2026, to approve several key resolutions. These include authorization for enhanced borrowing and investment limits aggregating up to ₹100 crore and specific approvals for transactions with promoters and holding companies.

Why this matters

These approvals are vital for Cian Healthcare's operational continuity and financial flexibility as it emerges from the Corporate Insolvency Resolution Process (CIRP). The ability to secure funds from promoters and related entities is crucial given limited access to institutional credit and higher interest costs.

Reader Takeaway: Promoter funding vital for revival; increased leverage and promoter dependency are key watch points.

The backstory

Cian Healthcare is relying on promoter-led financing post-CIRP, with an interest rate of 7.30% per annum. This includes loans for working capital and resource sharing agreements with Ananta Medicare Limited. The company aims to improve capacity utilization and operating margins within two years.

What changes now

Shareholder approval will grant the company the necessary financial headroom to operate and potentially expand. It will formalize the board appointments, including Mr. Rajesh Jain as Managing Director and Ms. Simmi Soni as a Woman Non-Executive Director.

Risks to watch

Key concerns include the company's high dependency on promoter group entities for financial and operational support. The Debt to Equity Ratio is projected to increase from 0.66 to 1.63 times after the transaction. Furthermore, the Debt Service Coverage Ratio (DSCR) remains negative, both before and after the proposed transactions.

Peer comparison

[Information not available in the filing]

Context metrics (time-bound)

• Materiality Threshold for RPT: ₹2.94 crore (FY 2026-27)
• Aggregate Borrowing/Loan/Guarantee Limit: ₹100 crore (Ongoing)
• Proposed Transaction Ceiling (Mr. Pradeep Kumar Jain): ₹61.12 crore (FY 2026-27)
• Proposed Transaction Ceiling (Mr. Rajesh Jain): ₹10.99 crore (FY 2026-27)
• Proposed Transaction Ceiling (Ananta Medicare Limited): ₹42.45 crore (FY 2026-27)
• Debt to Equity Ratio (Before Transaction): 0.66 times (FY 2025-26 audited)
• Debt to Equity Ratio (After Transaction): 1.63 times (FY 2025-26 audited)
• Postal Ballot Voting Period: June 10, 2026 – July 9, 2026
• Results Announcement: On or before July 13, 2026

What to track next

Investors will be looking for the company's performance in utilizing the approved funds, improvements in capacity utilization, and progress towards profitability within the next two years.